Due Oct122d left
STAR-FISH CALL 017 - Secure By Design
Dept of Defense · NM · due 4:00 PM MT
15 docs
What government contracts does The Emmes Company, LLC hold?
The Emmes Company, LLC holds 46 government contract awards worth $252M on RFPFinder, most from National Institutes of Health (46 awards), mainly under NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)) and NAICS 541690 (Other Scientific and Technical Consulting Services). 12 of them end in the next 12 months. The latest award on record is dated May 27, 2026.
Recent awards
latest 25 of 46, newest first| Awarded | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| May 27, 2026 | National Institutes of Health | EO 14398 STATISTICAL EXPERTISE FOR PROTEUS (TASK AREA 4) - CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOC…75N98026F00003 | $83K | Source |
| May 26, 2026 | National Institutes of Health | EO 14398 STATISTICAL EXPERTISE FOR OCD,75N98026F00002 | $20K | Source |
| Apr 30, 2026 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N98026F00001 | $402K | Source |
| Apr 29, 2026 | National Institutes of Health | DSC MANAGEMENT AND SUPPORT. APRIL 29, 2026 THROUGH FEBRUARY 28, 2027. N01DA-22-2253. TASK ORDER NO. 75N98026F00002 (TO…75N98026F00002 | $2.4M | Source |
| Apr 17, 2026 | National Institutes of Health | DSC MANAGEMENT AND SUPPORT. APRIL 15, 2026 THROUGH NOVEMBER 30, 2027 N01DA-22-2253, TASK ORDER NO. 75N98026F00001 (TO 2…75N98026F00001 | $670K | Source |
| Feb 27, 2026 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N92026F00002 | $191K | Source |
| Feb 27, 2026 | National Institutes of Health | DSC6 GENERAL MANAGEMENT AND SUPPORT. MARCH 1, 2026 TO APRIL 30, 2026. N01DA-22-2253. TASK ORDER NO. 75N95026F00001 (TO2…75N95026F00001 | $345K | Source |
| Feb 27, 2026 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N92026F00001 | $49K | Source |
| May 21, 2025 | National Institutes of Health | DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253…75N95025F00002 | $1.7M | Source |
| Feb 27, 2025 | National Institutes of Health | DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25).75N95025F00001 | $2.3M | Source |
| Feb 25, 2025 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N92025F00003 | $144K | Source |
| Feb 25, 2025 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N92025F00002 | $53K | Source |
| Aug 15, 2024 | National Institutes of Health | TASK ORDER 6 FOR THE CTN CLINICAL RESEARCH COORDINATING CENTER (CCC) CONTRACT75N98026F00001 | $5.0M | Source |
| Aug 14, 2024 | National Institutes of Health | RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INJECTABLE NALTREXONE AND MONTHLY INJECTABLE BUPRENORPHINE FOR COCAINE USE DISO…75N95024F00006 | $526K | Source |
| Aug 14, 2024 | National Institutes of Health | OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUS…75N95024F00007 | $1.9M | Source |
| Aug 13, 2024 | National Institutes of Health | CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES F…75N95024F00003 | $3.9M | Source |
| Aug 13, 2024 | National Institutes of Health | CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/202675N95024F00002 | $3.0M | Source |
| Aug 13, 2024 | National Institutes of Health | CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/2575N95024F00001 | $4.1M | Source |
| Aug 1, 2024 | National Institutes of Health | RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-…75N95024F00008 | $771K | Source |
| Feb 28, 2024 | National Institutes of Health | DSC MANAGEMENT AND SUPPORT. FEBRUARY 29, 2024 - FEBRUARY 28, 2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00002 (TO18).75N95024F00002 | $1.8M | Source |
| Feb 26, 2024 | National Institutes of Health | TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NID…75N95024F00001 | $2.0M | Source |
| Nov 29, 2023 | National Institutes of Health | PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER. 12/01/2023 - 03/31/2025. N01DA-22-2253. TA…75N95024F00001 | $375K | Source |
| Sep 15, 2023 | National Institutes of Health | STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (T…75N95023F00005 | $1.2M | Source |
| Sep 15, 2023 | National Institutes of Health | SECONDARY ANALYSIS. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2026. N01DA-22-2253. TASK ORDER NO. 75N95023F00012 (TO16)75N95023F00012 | $755K | Source |
| Sep 15, 2023 | National Institutes of Health | CRAFT. SEPTEMBER 15, 2023 - MARCH 31, 2025. N01DA-22-2253. TASK ORDER NO. 75N95023F00011 (TO15).75N95023F00011 | $800K | Source |
Pro ($39/mo) shows the latest 100 awards with a CSV export of every award. Sign in or upgrade
Contracts ending in the next 12 months
12 awards by period-of-performance end| Ends | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| Oct 31, 2026 | National Institutes of Health | EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH75N98022C00001 | $25M | Source |
| Nov 1, 2026 | National Institutes of Health | CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/202675N95024F00002 | $3.0M | Source |
| Jan 31, 2027 | National Institutes of Health | OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC H…75N95022F00003 | $1.9M | Source |
| Jan 31, 2027 | National Institutes of Health | STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (T…75N95023F00005 | $1.2M | Source |
| Feb 28, 2027 | National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS75N92026F00001 | $49K | Source |
Pro shows all 12 expiring awards.
Subcontracts received
3 subawards worth $7.4M reported by prime contractors| Prime contractor | Subawards | Value |
|---|---|---|
| Leidos Biomedical Research, Inc. | 2 | $4.1M |
| Digital Infuzion, Inc. | 1 | $3.4M |
Recent subawards
| Date | Prime · agency | Description | Amount | Prime award record |
|---|---|---|---|---|
| Aug 3, 2026 | Leidos Biomedical Research, Inc.National Institutes of Health | IN SUPPORT OF THE NIAID DMID H5N1 VACCINE CLINICAL TRIAL, LEIDOS BIOMED IS TASKED WITH THE MANAGEMENT OVERSIGHT AND CON… | $2.1M | Prime award |
| Sep 30, 2025 | Digital Infuzion, Inc.National Institutes of Health | EXERCISE AND FUND OY6. | $3.4M | Prime award |
| Dec 9, 2024 | Leidos Biomedical Research, Inc.National Institutes of Health | IN SUPPORT OF THE NIAID DMID H5N1 VACCINE CLINICAL TRIAL, LEIDOS BIOMED IS TASKED WITH THE MANAGEMENT OVERSIGHT AND CON… | $2.0M | Prime award |
Open solicitations The Emmes Company, LLC could bid on
All 109 under NAICS 541715Open notices under NAICS 541715, The Emmes Company, LLC's most frequent industry code, soonest deadline first.
Questions about The Emmes Company, LLC
What does The Emmes Company, LLC sell to the government?
The Emmes Company, LLC's awards on RFPFinder fall mostly under NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)), NAICS 541690 (Other Scientific and Technical Consulting Services) and PSC AN11. Its most common product and service code is AN11, on 30 awards.
Which agencies buy from The Emmes Company, LLC?
National Institutes of Health (46 awards) is the buyer from The Emmes Company, LLC on RFPFinder, out of 1 agency in total.
How much has The Emmes Company, LLC been awarded in government contracts?
$252M across 46 awards on RFPFinder, June 2014 to May 2026. That is the sum of the award records RFPFinder holds, not a complete history of The Emmes Company, LLC's government revenue.
Which prime contractors subcontract to The Emmes Company, LLC?
Prime contractors reported 3 subawards to The Emmes Company, LLC worth $7.4M on USAspending.gov, most from Leidos Biomedical Research, Inc. ($4.1M) and Digital Infuzion, Inc. ($3.4M). These are the subawards under prime contracts for the agencies and codes RFPFinder tracks.
How do I find The Emmes Company, LLC's UEI or CAGE code?
The Emmes Company, LLC's UEI on its federal awards is NBQCBJ6FXBU4. Award records do not carry CAGE codes; search the UEI in SAM.gov's entity search to see the CAGE code and registration status.
Vendor totals add up the award records RFPFinder holds: federal contract awards from USAspending.gov for the agencies and codes behind open notices, and state and local awards from open-data contract registers and purchase-order files. They are not a vendor's complete government revenue, and a register that lists a contract ceiling or repeats a contract can overstate spend. Names are grouped across spellings ("Corp" and "Corporation"); each award links to its source record. Subcontracts are prime contractors' subaward reports on USAspending.gov for the prime awards behind the same agencies and codes, and GSA Schedule contracts come from GSA eLibrary's MAS contractor list; both are matched to vendors by name.